p38 inhibitors for the treatment and prophylaxis of live cancer

Publication:
p38 inhibitors for the treatment and prophylaxis of live cancer

dc.contributor.author	Sabio, Guadalupe
dc.contributor.author	Tomas-Loba, Antonia
dc.contributor.author	Martinez Gil, Ana
dc.contributor.author	Gil Ayuso-Gontan, Carmen
dc.contributor.author	Gonzalez-Teran, Barbara
dc.contributor.author	Manieri, Elisa
dc.contributor.department	Fisiología
dc.date.accessioned	2024-02-12T08:47:41Z
dc.date.available	2024-02-12T08:47:41Z
dc.date.issued	2016
dc.description	International Publication Number: WO 2016/198698 A3 (WIPO/PCT)
dc.description.abstract	The present invention provides p38 inhibitors which are useful for the treatment and/or prophylaxis of liver cancer. In particular, the present invention provides compounds capable of inhibiting the intracellular expression of the p38 gamma protein in the hepatocytes of a subject relative to that observed in the absence of the compound, for use in the therapeutic treatment of liver cancer.
dc.format	application/pdf	es
dc.format.extent	8	es
dc.identifier.uri	http://hdl.handle.net/10201/139267
dc.language	eng	es
dc.publisher	World Intellectual Property Organization, International Bureau	es
dc.relation	Sin financiación externa a la Universidad	es
dc.rights.accessRights	info:eu-repo/semantics/restrictedAccess
dc.subject.other	CDU::5 - Ciencias puras y naturales::57 - Ciencias biológicas en general:577 - 577 Bioquímica. Biología molecular. Biofísica
dc.title	p38 inhibitors for the treatment and prophylaxis of live cancer	es
dc.type	info:eu-repo/semantics/patent	es
dspace.entity.type	Publication	es